Watch speakers from across the clinical spectrum to discuss the impact of genomic profiling to benefit cancer patients through precision therapies.
Topics covered include:

Kevin Keegan
Vice President and General Manager, Oncology
Illumina

Phil Febbo, MD
Chief Medical Officer
Illumina

David Bartlett, MD
Chair
Allegheny Health Network (AHN) Cancer Institute

Sandip Patel, MD
Associate Professor of Medicine
University of California, San Diego
Rachel Sanborn, MD
Medical Oncologist
Earle A. Chiles Research Institute
Providence Cancer Institute
Your email address is never shared with third parties.